Drugs / EVG
last change Nov 2017 re-read 2 minutes ago

EVG

Developed for
HIV infectious disease
Investigated by
Gilead Sciences

Trials 1 · a red edge is where a trial was stopped

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2/3 NCT01923311 Aug 2013 → Nov 2017 AIDS Gilead Sciences Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as EVG ClinicalTrials.gov intervention name — accepted as the source's own label NCT01923311